These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 32849449)

  • 1. CoronaVR: A Computational Resource and Analysis of Epitopes and Therapeutics for Severe Acute Respiratory Syndrome Coronavirus-2.
    Gupta AK; Khan MS; Choudhury S; Mukhopadhyay A; Sakshi ; Rastogi A; Thakur A; Kumari P; Kaur M; Shalu ; Saini C; Sapehia V; Barkha ; Patel PK; Bhamare KT; Kumar M
    Front Microbiol; 2020; 11():1858. PubMed ID: 32849449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NipahVR: a resource of multi-targeted putative therapeutics and epitopes for the Nipah virus.
    Gupta AK; Kumar A; Rajput A; Kaur K; Dar SA; Thakur A; Megha K; Kumar M
    Database (Oxford); 2020 Jan; 2020():. PubMed ID: 32090261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural, glycosylation and antigenic variation between 2019 novel coronavirus (2019-nCoV) and SARS coronavirus (SARS-CoV).
    Kumar S; Maurya VK; Prasad AK; Bhatt MLB; Saxena SK
    Virusdisease; 2020 Mar; 31(1):13-21. PubMed ID: 32206694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing and Contrasting MERS, SARS-CoV, and SARS-CoV-2: Prevention, Transmission, Management, and Vaccine Development.
    Oves M; Ravindran M; Rauf MA; Omaish Ansari M; Zahin M; Iyer AK; Ismail IMI; Khan MA; Palaniyar N
    Pathogens; 2020 Nov; 9(12):. PubMed ID: 33255989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a novel platform of virus-like particle (VLP)-based vaccine against COVID-19 by exposing epitopes: an immunoinformatics approach.
    Ghorbani A; Zare F; Sazegari S; Afsharifar A; Eskandari MH; Pormohammad A
    New Microbes New Infect; 2020 Nov; 38():100786. PubMed ID: 33072338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ZikaVR: An Integrated Zika Virus Resource for Genomics, Proteomics, Phylogenetic and Therapeutic Analysis.
    Gupta AK; Kaur K; Rajput A; Dhanda SK; Sehgal M; Khan MS; Monga I; Dar SA; Singh S; Nagpal G; Usmani SS; Thakur A; Kaur G; Sharma S; Bhardwaj A; Qureshi A; Raghava GP; Kumar M
    Sci Rep; 2016 Sep; 6():32713. PubMed ID: 27633273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The COVID-19 puzzle: a global nightmare.
    Mahrosh HS; Mustafa G
    Environ Dev Sustain; 2021; 23(9):12710-12737. PubMed ID: 33551672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of COVID-19, SARS and MERS.
    Hu T; Liu Y; Zhao M; Zhuang Q; Xu L; He Q
    PeerJ; 2020; 8():e9725. PubMed ID: 32879801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ensemble Machine Learning Model to Predict SARS-CoV-2 T-Cell Epitopes as Potential Vaccine Targets.
    Bukhari SNH; Jain A; Haq E; Mehbodniya A; Webber J
    Diagnostics (Basel); 2021 Oct; 11(11):. PubMed ID: 34829338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2019-nCoV - Towards a 4th generation vaccine.
    Chiappelli F
    Bioinformation; 2020; 16(2):139-144. PubMed ID: 32405164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design.
    Wang D; Mai J; Zhou W; Yu W; Zhan Y; Wang N; Epstein ND; Yang Y
    Vaccines (Basel); 2020 Jul; 8(3):. PubMed ID: 32635180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 isolation and propagation from Turkish COVID-19 patients.
    TaŞtan C; Yurtsever B; Sir KarakuŞ G; Dİlek KanÇaĞi D; Demİr S; Abanuz S; Seyİs U; Yildirim M; Kuzay R; Elİbol Ö; Arbak S; AÇikel Elmas M; BİrdoĞan S; Sezerman OU; KocagÖz AS; YalÇin K; Ovali E
    Turk J Biol; 2020; 44(3):192-202. PubMed ID: 32595356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic potential of miRNAs targeting SARS-CoV-2 host cell receptor ACE2.
    Bozgeyik I
    Meta Gene; 2021 Feb; 27():100831. PubMed ID: 33224734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Machine Learning Techniques for the Prediction of B-Cell and T-Cell Epitopes as Potential Vaccine Targets with a Specific Focus on SARS-CoV-2 Pathogen: A Review.
    Bukhari SNH; Jain A; Haq E; Mehbodniya A; Webber J
    Pathogens; 2022 Jan; 11(2):. PubMed ID: 35215090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-silico strategies to combat COVID-19: A comprehensive review.
    Basu S; Ramaiah S; Anbarasu A
    Biotechnol Genet Eng Rev; 2021 Apr; 37(1):64-81. PubMed ID: 34470564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The New Coronavirus COVID-19 Infection.
    Bevova MR; Netesov SV; Aulchenko YS
    Mol Gen Microbiol Virol; 2020; 35(2):53-60. PubMed ID: 32929302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolutionary Analysis of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reveals Genomic Divergence with Implications for Universal Vaccine Efficacy.
    Yellapu NK; Patel S; Zhang B; Meier R; Neums L; Pei D; Xia Q; Rotich D; Zimmermann RC; Nissen E; Bell-Glenn S; Shae W; Hu J; Chalise P; Chollet-Hinton L; Koestler DC; Thompson JA
    Vaccines (Basel); 2020 Oct; 8(4):. PubMed ID: 33050053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and Analysis of Unstructured, Linear B-Cell Epitopes in SARS-CoV-2 Virion Proteins for Vaccine Development.
    Corral-Lugo A; López-Siles M; López D; McConnell MJ; Martin-Galiano AJ
    Vaccines (Basel); 2020 Jul; 8(3):. PubMed ID: 32698423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probiotic-Based Vaccines May Provide Effective Protection against COVID-19 Acute Respiratory Disease.
    Taghinezhad-S S; Mohseni AH; Bermúdez-Humarán LG; Casolaro V; Cortes-Perez NG; Keyvani H; Simal-Gandara J
    Vaccines (Basel); 2021 May; 9(5):. PubMed ID: 34066443
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.